• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Dehydrocorydaline

Dehydrocorydaline

Product ID D1631
Cas No. 30045-16-0
Purity ≥95%
Product Unit SizeCostQuantityStock
1 mg $127.70 In stock
5 mg $501.30 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Dehydrocorydaline is an alkaloid compound originally found in Corydalis tubers that exhibits anticancer, anti-inflammatory, and anti-allergic activities. In breast cancer cells, dehydrocorydaline increases activation of caspases 7 and 8, cleavage of poly(ADP)-ribose polymerase (PARP), and the Bax/Bcl-2 ratio, inducing DNA fragmentation and inhibiting proliferation. In macrophages, this compound inhibits LPS-induced increases in IL-6 and IL-1β as well as alterations in the mitochondrial membrane potential. Dehydrocorydaline inhibits passive cutaneous anaphylaxis (type I hypersensitivity), contact dermatitis (type IV hypersensitivity), and mast cell degranulation in animal models of allergies. Additionally, dehydrocorydaline also inhibits acetylcholinesterase (AChE).

Product Info

Cas No.

30045-16-0

Purity

≥95%

Formula

C22H24NO4

Formula Wt.

366.43

IUPAC Name

2,3,9,10-tetramethoxy-13-methyl-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium

Solubility

10 mM in DMSO

Appearance

Yellow powder

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

D1631 MSDS PDF

Info Sheet

D1631 Info Sheet PDF

References

Xu Z, Chen X, Fu S, et al. Dehydrocorydaline inhibits breast cancer cells proliferation by inducing apoptosis in MCF-7 cells. Am J Chin Med. 2012;40(1):177-85. Erratum in: Am J Chin Med. 2012;40(6):1323. PMID: 22298457.

Ishiguro K, Ando T, Maeda O, et al. Dehydrocorydaline inhibits elevated mitochondrial membrane potential in lipopolysaccharide-stimulated macrophages. Int Immunopharmacol. 2011 Sep;11(9):1362-7. PMID: 21575743.

Xiao HT, Peng J, Liang Y, et al. Acetylcholinesterase inhibitors from Corydalis yanhusuo. Nat Prod Res. 2011 Sep;25(15):1418-22. PMID: 20234973.

Matsuda H, Tokuoka K, Wu J, et al. Inhibitory effects of dehydrocorydaline isolated from Corydalis Tuber against type I-IV allergic models. Biol Pharm Bull. 1997 Apr;20(4):431-4. PMID: 9145224.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • M1845

    Melitracen Hydrochloride

    Tricyclic antidepressant; potential D1/2 antago...

    ≥99%
  • A6269

    Apremilast

    PDE4 inhibitor.

    ≥98%
  • V0352

    Vandetanib

    RET, EGFR, VEGFR2 inhibitor.

    ≥98%
  • P3198

    Phytanic Acid

    Fatty acid metabolite of chlorophyll; RXR and P...

    ≥97%
  • G8800

    GW-788388

    ALK5 (activin-like) antagonist.

    ≥97%
  • C1621

    CEF4

    Peptide, vSrc-induced cytokine.

    ≥95%
  • C9608

    Cycloastragenol

    Triterpene aglycone found in Radix Astragali; t...

    ≥98%
  • B3320

    Bifonazole

    Imidazole; HMG-CoA reductase, 14-α demethylase...

    ≥98%
  • N3496

    Nizatidine

    Histamine H2 inverse agonist.

    ≥98%
  • I0801

    IC261

    Casein kinase 1 inhibitor.

    ≥98%
  • B1992

    Bexarotene

    RXR agonist.

    ≥98%
  • M1708

    Mecamylamine Hydrochloride

    Monoterpene; nAChR antagonist.

    ≥98%
  • F4557

    Floxuridine

    5-Fluorouracil derivative, fluorinated pyrimidi...

    ≥98%
  • T503720

    TMS

    Selective inhibitor of cytochrome P450 1B1 (CYP...

    ≥99%
  • F4883

    Flutriafol

    Triazole; demethylation inhibitor, NMDA agonist...

    ≥97%
  • B3300

    BI-6727

    PLK1 inhibitor.

    ≥99%
  • O1176

    n-Octyl Caffeate

    Caffeic acid derivative.

    ≥98%
  • G3351

    Ginkgolic Acid (17:1)

    Mixture of alkylphenols found in Ginkgo; HIV pr...

    ≥98%
  • A5160

    Ampicillin Trihydrate

    β-lactam; transpeptidase inhibitor.

    ≥97%
  • E5217

    β-Endorphin, human

    Endogenous opioid peptide; μOR agonist.

    ≥95%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only